Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Dow
UBS
Mallinckrodt
Queensland Health
US Army
Chubb
Healthtrust
Farmers Insurance
Fuji

Generated: February 23, 2018

DrugPatentWatch Database Preview

Imipramine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for imipramine hydrochloride and what is the scope of imipramine hydrochloride patent protection?

Imipramine hydrochloride
is the generic ingredient in five branded drugs marketed by Novartis, Leading Pharma Llc, Lederle, Lupin Ltd, Oxford Pharms, Par Pharm, Roxane, Sandoz, Specgx Llc, Sun Pharm Industries, Teva, Usl Pharma, Vangard, Watson Labs, West Ward, Abbott, Alra, and Sanofi Aventis Us, and is included in forty NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-four drug master file entries for imipramine hydrochloride. Nineteen suppliers are listed for this compound.
Pharmacology for imipramine hydrochloride

US Patents and Regulatory Information for imipramine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Industries IMIPRAMINE HYDROCHLORIDE imipramine hydrochloride TABLET;ORAL 081048-001 Jun 5, 1990 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Leading Pharma Llc IMIPRAMINE HYDROCHLORIDE imipramine hydrochloride TABLET;ORAL 040903-003 Oct 24, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs IMIPRAMINE HYDROCHLORIDE imipramine hydrochloride TABLET;ORAL 085221-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Specgx Llc IMIPRAMINE HYDROCHLORIDE imipramine hydrochloride TABLET;ORAL 087846-002 May 22, 1984 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs IMIPRAMINE HYDROCHLORIDE imipramine hydrochloride TABLET;ORAL 084252-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us PRESAMINE imipramine hydrochloride TABLET;ORAL 011836-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vangard IMIPRAMINE HYDROCHLORIDE imipramine hydrochloride TABLET;ORAL 087619-001 Feb 9, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West Ward IMIPRAMINE HYDROCHLORIDE imipramine hydrochloride TABLET;ORAL 088223-001 May 26, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West Ward IMIPRAMINE HYDROCHLORIDE imipramine hydrochloride TABLET;ORAL 088222-001 May 26, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbott JANIMINE imipramine hydrochloride TABLET;ORAL 017895-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Accenture
Dow
Julphar
Teva
Colorcon
Express Scripts
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot